参考文献/References:
[1] Litak J,Mazurek M,Kulesza B,et al.Cerebral small vessel disease[J].Int J Mol Sci,2020,21(24):9729.
[2] Grochowski C,Litak J,Kamieniak P,et al.Oxidative stress in cerebral small vessel disease.Role of reactive species[J].Free Radic Res,2018,52(1):1-13.
[3] 胡文立,杨磊,李譞婷,等.中国脑小血管病诊治专家共识2021[J].中国卒中杂志,2021,16(7):716-726.
[4] 吴茂东,杜海敏,赵秦,等.外泌体在脑缺血中的信号传递作用[J].国际脑血管病杂志,2020,28(2):145-149.
[5] 赖梅菁,徐恩,邱美茜,等.外泌体在脑缺血后神经炎症中的作用[J].国际脑血管病杂志,2021,29(2):132-137.
[6] Fauré J,Lachenal G,Court M,et al.Exosomes are released by cultured cortical neurones[J].Mol Cell Neurosci,2006,31(4):642-648.
[7] Treiber T,Treiber N,Meister G.Regulation of microRNA biogenesis and its crosstalk with other cellular pathways[J].Nat Rev Mol Cell Biol,2019,20(1):5-20.
[8] Zhao WN,Sun WQ,Li SO,et al.Exosomal miRNA-223-3p as potential biomarkers in patients with cerebral small vessel disease cognitive impairment[J].Ann Transl Med,2021,9(24):1781.
[9] Iadecola C.The neurovascular unit coming of age: a journey through neurovascular coupling in health and disease[J].Neuron,2017,96(1):17-42.
[10] 周惠敏,王艳,宋芳星,等.脑小血管病的发病机制[J].国际脑血管病杂志,2023,31(2):146-150.
[11] 陈晓雪,聂海宏,张忠玲.内皮功能障碍与脑小血管病[J].国际脑血管病杂志,2020,28(9):693-696.
[12] 李凤,谭守文,李影,等.血脑屏障完整性与脑小血管病[J].国际脑血管病杂志,2017,25(3):239-243.
[13] Gupta M,Lee HJ,Barden CJ,et al.The Blood-brain barrier(BBB)score[J].J Med Chem,2019,62(21):9824-9836.
[14] Douven E,Staals J,Freeze WM,et al.Imaging markers associated with the development of post-stroke depression and apathy: results of the cognition and affect after stroke - a prospective evaluation of risks study[J].Eur Stroke J,2020,5(1):78-84.
[15] Bai T,Yu SJ,Feng J.Advances in the role of endothelial cells in cerebral small vessel disease[J].Front Neurol,2022,13:861714.
[16] Thrippleton MJ,Backes WH,Sourbron S,et al.Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations[J].Alzheimers Dement,2019,15(6):840-858.
[17] Young VG,Halliday GM,Kril JJ.Neuropathologic correlates of white matter hyperintensities[J].Neurology,2008,71(11):804-811.
[18] Farrall AJ,Wardlaw JM.Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis[J].Neurobiol Aging,2009,30(3):337-352.
[19] Guo Y,Li DX,Li JP,et al.Expression and significance of MicroRNA155 in serum of patients with cerebral small vessel disease[J].J Korean Neurosurg Soc,2020,63(4):463-469.
[20] Yasmeen S,Kaur S,Mirza AH,et al.miRNA-27a-3p and miRNA-222-3p as novel modulators of phosphodiesterase 3a(PDE3A)in cerebral microvascular endothelial cells[J].Mol Neurobiol,2019,56(8):5304-5314.
[21] Goerke SM,Kiefer LS,Stark GB,et al.miR-126 modulates angiogenic growth parameters of peripheral blood endothelial progenitor cells[J].Biol Chem,2015,396(3):245-252.
[22] Ebrahimi V,Rastegar-Moghaddam SH,Mohammadipour A.Therapeutic potentials of microRNA-126 in cerebral ischemia[J].Mol Neurobiol,2023,60(4):2062-2069.
[23] Wang CY,Cao JW,Duan SR,et al.Effect of microRNA-126a-3p on bone marrow mesenchymal stem cells repairing blood-brain barrier and nerve injury after intracerebral hemorrhage[J].J Stroke Cerebrovasc Dis,2020,29(5):104748.
[24] Fu X,Niu TS,Li XD.MicroRNA-126-3p attenuates intracerebral hemorrhage-induced blood-brain barrier disruption by regulating VCAM-1 expression[J].Front Neurosci,2019,13:866.
[25] Xiao X,Xu MQ,Yu HL,et al.Mesenchymal stem cell-derived small extracellular vesicles mitigate oxidative stress-induced senescence in endothelial cells via regulation of miR-146a/Src[J].Signal Transduct Target Ther,2021,6(1):354.
[26] Gao Z,Gao Q,Lv XD.MicroRNA-668-3p protects against oxygen-glucose deprivation in a rat H9c2 cardiomyocyte model of Ischemia-Reperfusion injury by targeting the stromal cell-derived factor-1(SDF-1)/CXCR4 signaling pathway[J].Med Sci Monit,2020,26:e919601.
[27] He JN,Zhang XJ.MiR-668 inhibitor attenuates mitochondrial membrane potential and protects against neuronal apoptosis in cerebral ischemic stroke[J].Folia Neuropathol,2020,58(1):22-29.
[28] Wang JJ,Chen SZ,Ma XT,et al.Effects of endothelial progenitor cell-derived microvesicles on hypoxia/reoxygenation-induced endothelial dysfunction and apoptosis[J].Oxid Med Cell Longev,2013,2013:572729.
[29] Wang JJ,Chen YS,Yang Y,et al.Endothelial progenitor cells and neural progenitor cells synergistically protect cerebral endothelial cells from Hypoxia/reoxygenation-induced injury via activating the PI3K/Akt pathway[J].Mol Brain,2016,9(1):12.
[30] Liu H,Wang JJ,Chen YS,et al.NPC-EXs alleviate endothelial oxidative stress and dysfunction through the miR-210 downstream Nox2 and VEGFR2 pathways[J].Oxid Med Cell Longev,2017,2017:9397631.
[31] Che F,Han YF,Fu JX,et al.LncRNA MALAT1 induced by hyperglycemia promotes microvascular endothelial cell apoptosis through activation of the miR-7641/TPR axis to exacerbate neurologic damage caused by cerebral small vessel disease[J].Ann Transl Med,2021,9(24):1762.
[32] Zhao Z,Zlokovic BV.Remote control of BBB: a tale of exosomes and microRNA[J].Cell Res,2017,27(7):849-850.
[33] Rawal S,Munasinghe PE,Shindikar A,et al.Down-regulation of proangiogenic microRNA-126 and microRNA-132 are early modulators of diabetic cardiac microangiopathy[J].Cardiovasc Res,2017,113(1):90-101.
[34] Pan QW,Kuang XL,Cai SY,et al.MiR-132-3p priming enhances the effects of mesenchymal stromal cell-derived exosomes on ameliorating brain ischemic injury[J].Stem Cell Res Ther,2020,11(1):260.
[35] Low A,Mak E,Rowe JB,et al.Inflammation and cerebral small vessel disease: a systematic review[J].Ageing Res Rev,2019,53:100916.
[36] Shoamanesh A,Preis SR,Beiser AS,et al.Inflammatory biomarkers, cerebral microbleeds, and small vessel disease: framingham heart study[J].Neurology,2015,84(8):825-832.
[37] Bertrand L,Dygert L,Toborek M.Antiretroviral treatment with efavirenz disrupts the blood-brain barrier integrity and increases stroke severity[J].Sci Rep,2016,6:39738.
[38] Schlunk F,Pfeilschifter W,Yigitkanli K,et al.Treatment with FTY720 has no beneficial effects on short-term outcome in an experimental model of intracerebral hemorrhage[J].Exp Transl Stroke Med,2016,8:1.
[39] Yu CY,Lu WZ,Qiu JF,et al.Alterations of the whole cerebral blood flow in patients with different total cerebral small vessel disease burden[J].Front Aging Neurosci,2020,12:175.
[40] Dolati S,Aghebati-Maleki L,Ahmadi M,et al.Nanocurcumin restores aberrant miRNA expression profile in multiple sclerosis, randomized, double-blind, placebo-controlled trial[J].J Cell Physiol,2018,233(7):5222-5230.
[41] Gao KJ,Yin RH,Wang Y,et al.Exosomal miR-320e as a novel potential biomarker for cerebral small vessel disease[J].Int J Gen Med,2023,16:641-655.
[42] Tang HC,Lai YY,Zheng J,et al.miR-223-3p inhibits antigen endocytosis and presentation and promotes the tolerogenic potential of dendritic cells through targeting mannose receptor signaling and Rhob[J].J Immunol Res,2020,2020:1379458.
[43] Yu P,Venkat P,Chopp M,et al.Role of microRNA-126 in vascular cognitive impairment in mice[J].J Cereb Blood Flow Metab,2019,39(12):2497-2511.
[44] Morquette B,Ju('overz)wik CA,Drake SS,et al.MicroRNA-223 protects neurons from degeneration in experimental autoimmune encephalomyelitis[J].Brain,2019,142(10):2979-2995.
[45] Zhao YM,Gan YX,Xu GW,et al.Exosomes from MSCs overexpressing microRNA-223-3p attenuate cerebral ischemia through inhibiting microglial M1 polarization mediated inflammation[J].Life Sci,2020,260:118403.